These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 150133

  • 1. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N.
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract] [Full Text] [Related]

  • 2. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA, Pavlovsky M, Martínez Canaveri A.
    Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494
    [No Abstract] [Full Text] [Related]

  • 3. [Blood coagulation activity and fibrinolysis in umbilical vein blood of healthy and asphyxiated newborn infants].
    Schander K, Rehm A, Niesen M.
    Fortschr Med; 1977 Jun 09; 95(22):1477-81. PubMed ID: 873434
    [Abstract] [Full Text] [Related]

  • 4. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M, Kim BK, Kim S, Park S, Han JS, Kim ST, Lee JS.
    Rev Infect Dis; 1989 Jun 09; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [Abstract] [Full Text] [Related]

  • 5. [Fibrinolysis].
    Levy G, Michault A, Jamet M.
    Ann Anesthesiol Fr; 1978 Jun 09; 19(8):703-8. PubMed ID: 31114
    [Abstract] [Full Text] [Related]

  • 6. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
    Kawai Y.
    Nihon Rinsho; 2004 Dec 09; 62 Suppl 12():618-22. PubMed ID: 15658405
    [No Abstract] [Full Text] [Related]

  • 7. The hematologic consequences of thrombolytic therapy.
    Fletcher AP, Alkjaersig NK.
    Prog Hematol; 1986 Dec 09; 14():183-200. PubMed ID: 2935903
    [No Abstract] [Full Text] [Related]

  • 8. [The problem of hemostatic disorders following extracorporeal circulation].
    Flesch R.
    Thoraxchir Vask Chir; 1969 Oct 09; 17(5):422-6. PubMed ID: 4249415
    [No Abstract] [Full Text] [Related]

  • 9. Fibrinolytic activity in gastric venous blood. A comparison between normal and diseased stomachs.
    O'Brien TE, Hadley H, Irving MH.
    Gastroenterology; 1979 Mar 09; 76(3):509-14. PubMed ID: 155020
    [Abstract] [Full Text] [Related]

  • 10. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ, Shulman NR, Carroll WR.
    Trans Assoc Am Physicians; 1967 Mar 09; 80():156-67. PubMed ID: 4230117
    [No Abstract] [Full Text] [Related]

  • 11. [Necessary diagnosis of hemostasis for surgical practice].
    Lasch HG, Krause W.
    Chirurg; 1967 Dec 09; 38(12):541-5. PubMed ID: 5626747
    [No Abstract] [Full Text] [Related]

  • 12. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C, Barton MH, Prasse KW, Moore JN.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):465-70. PubMed ID: 7591947
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP, Niewiarowski S, Myers AR, Bloch KJ, Colman RW.
    N Engl J Med; 1970 Sep 24; 283(13):663-8. PubMed ID: 4247823
    [No Abstract] [Full Text] [Related]

  • 14. Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma.
    Scully MF, Kakkar VV.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):584. PubMed ID: 53894
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in blood coagulation in glomerulonephritis].
    Robeva R, Belovezhdov N, Genova V.
    Vutr Boles; 1982 Nov 15; 21(6):1-7. PubMed ID: 6219496
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A, Vermylen J, Verstraete M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Nov 15; 92(1):7-19. PubMed ID: 4189377
    [No Abstract] [Full Text] [Related]

  • 17. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1993 Jul 15; 41(7):743-9. PubMed ID: 8361043
    [Abstract] [Full Text] [Related]

  • 18. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M, Watanabe T, Ooka F, Liang SG, Aisaka K, Okinaga S.
    Clin Hemorheol Microcirc; 2001 Jul 15; 24(2):93-9. PubMed ID: 11381184
    [Abstract] [Full Text] [Related]

  • 19. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y, Watanabe K.
    Rinsho Byori; 1989 Mar 15; 37(3):248-55. PubMed ID: 2526263
    [No Abstract] [Full Text] [Related]

  • 20. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
    Nagayama M, Tachibana A, Hayakawa H, Sato A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb 15; 31(2):180-5. PubMed ID: 8390588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.